INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 434m ago
HOUSE PTR34m ago
SEC 13F34m ago
ROBINHOOD CHAIN34m ago
SEC FORM 4/Open-market purchaseVerified data

Kumar Amit bought ANIX

Director, Chief Executive Officer · Anixa Biosciences Inc · Common Stock

Side
BUY
Value
$22K
Shares
8,000
Price
$2.72
Executed
Oct 22, 2026
Disclosed
Oct 22, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Oct 22 executedOct 22, 2026 disclosed

ANIX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
34/ 100 · ELEVATED
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+1 / 25

    $22K reported value · 1.2% of prior position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ANIX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    34
    TH
    Titterton Lewis H jrDirector
    ANIXAnixa Biosciences Inc
    Open-market purchase
    		BUY$24K
    8,000 sh
    		Oct 23, 2026Oct 26, 2026
    traded Oct 23, 2026
    		+3dSEC FORM 4

    Evidence

    33
    CM
    Catelani MichaelPresident, COO, & CFO
    ANIXAnixa Biosciences Inc
    Open-market purchase
    		BUY$16K
    5,500 sh
    		Sep 30, 2026Sep 30, 2026
    traded Sep 30, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001493152-26-048144
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 22, 2026
    Published
    Oct 22, 2026
    Ingested by INSIDER
    Nov 5, 02:10 UTC
    Last re-read
    Nov 5, 02:10 UTC

    Extracted facts

    Filer
    Kumar Amit
    Role
    Director, Chief Executive Officer
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Anixa Biosciences Inc
    Ticker
    ANIX
    Shares
    8,000
    Price per share
    $2.72
    Value
    $21,760
    Execution date (reported)
    Oct 22, 2026
    Owned after transaction
    680.0K shares
    Days from execution to publication
    0

    Calculation

    Value = shares × reported price per share

    • Shares: 8,000
    • Price: $2.72

    = $21,760

    What this establishes

    Kumar Amit filed this Form 4 reporting a open-market purchase of ANIX on Oct 22, 2026. It became public on Oct 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Chief Executive Officer
    Kumar Amitcik:0001191905
    Issuer
    Anixa Biosciences Inccik:0000715446

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.